2024
Representation of female vascular surgeons in national clinical trial leadership: analysis of trends over 20 years
Kostiuk V, Thaxton C, Loh S, Cardella J, Dardik A, Tonnessen B. Representation of female vascular surgeons in national clinical trial leadership: analysis of trends over 20 years. JVS-Vascular Insights 2024, 2: 100077. DOI: 10.1016/j.jvsvi.2024.100077.Peer-Reviewed Original ResearchClinical trialsFemale vascular surgeonsVascular surgeonsMethods Clinical trialsArtery diseaseClinical trial leadershipSite principal investigatorsVascular conditionsAbdominal aortic aneurysmSurgeon-investigatorInvestigator-led trialsCarotid artery diseasePeripheral arterial diseaseCarotid diseaseProportion of womenVenous thrombectomyBoard certificationAortic aneurysmPercentage of womenIndustry-sponsored trialsTrial leadershipHemodialysis accessSubgroup analysisVascular surgerySurgeons
2023
Modalities to Deliver Cell Therapy for Treatment of Chronic Limb Threatening Ischemia
Setia O, Lee S, Dardik A. Modalities to Deliver Cell Therapy for Treatment of Chronic Limb Threatening Ischemia. Advances In Wound Care 2023, 13: 253-279. PMID: 37002893, PMCID: PMC11305013, DOI: 10.1089/wound.2022.0114.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsChronic limb threatening ischemiaPeripheral arterial diseaseSevere peripheral arterial diseaseLimb threatening ischemiaClinical trialsCell therapyStem cell therapyIschemic limbsFeasible therapeutic alternativePromising treatment optionPre-clinical studiesCell deliveryPAD patientsArterial diseaseClinical benefitTreatment optionsSurgical methodsTherapeutic alternativeBest modalityHigh riskLimb lossSevere formTherapeutic benefitPatientsTherapy
2021
Chapter 13 Assessment of female sex in preclinical vascular models
Gao M, Gorecka J, Liu J, Dardik A. Chapter 13 Assessment of female sex in preclinical vascular models. 2021, 349-385. DOI: 10.1016/b978-0-12-822959-0.00005-5.ChaptersAneurysm formationSequelae of atherosclerosisArteriovenous fistula maturationPathophysiology of atherosclerosisCause of deathPositive vessel remodelingAtherosclerotic complicationsFistula maturationFemale sexVenous remodelingClinical trialsInflammatory responseSex hormonesCardiovascular diseaseDisease outcomePreclinical studiesAnimal modelsProtective roleAtherosclerosisLipid metabolismVessel remodelingFemale animalsOxidative stressNational InstituteNumber of participants
2020
Stem Cell Therapy to Improve Acute Myocardial Infarction Remodeling
Gorecka J, Dardik A. Stem Cell Therapy to Improve Acute Myocardial Infarction Remodeling. 2020, 299-329. DOI: 10.1007/978-3-030-56954-9_14.ChaptersHeart failureMyocardial infarctionClinical trialsEjection fractionCellular sourceCell therapyEnd-stage pathologyCause of deathStem cell efficacyStem cell treatmentStem cell therapyMI injuryVentricular dilationModest efficacyMyocardial recoveryHeart diseaseRemodeling changesSurgical careIschemic environmentAdult myocardiumDelivery methodsCell efficacyCell treatmentLack of standardizationTrials